Medtronic plc. (MDT)
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MDT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $112.24B
- P/E (TTM)
- 21.56
- Forward P/E
- 13.68
- EPS (TTM)
- $4.07
- Dividend yield
- 3.25% ($2.85)
- Ex-dividend date
- Sep 25, 2026
- 52-week range
- 73.31 – 106.33
- Day range
- 85.55 – 88.48
- Volume / Avg
- 105.66M / 11.49M
- Beta
- —
- Shares outstanding
- 1.28B
52-week range
MDT stock today
On Oct 8, MDT ended the session at $87.75, adding $2.24 (2.62%), versus the S&P 500's 0.47% decline. Volume was 9.2x the average at 105.66M shares, a sign of unusually heavy trading. Shares are 17.5% below their 52-week high of $106.33, set on Nov 26, 2025 and 19.7% above the 52-week low of $73.31, in the middle of the past year's range.
MDT is down 8.7% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 10.3%. At 21.6x trailing earnings, Medtronic trades in line with the peer-group median of 22.5x. Its forward P/E of 13.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Medtronic pays an annual dividend of $2.85 per share, a 3.25% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Medtronic
Company profileMedtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Geoffrey Straub Martha
- Headquarters
- Galway
- Employees
- 95,000
- Website
- medtronic.com
Financial highlights
Full financialsIn fiscal 2026, Medtronic generated $36.36 billion in revenue, up 8.4% from fiscal 2025, its 3rd consecutive year of revenue growth. Net income was $4.80 billion (+3.0% year over year), for a net margin of 13.2% versus a median of 12.0% in the prior 5 years. Gross margin was 65.0% (down from 65.3%) and operating margin 17.8%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B |
| Growth | +8.43% | +3.62% | +3.64% | -1.45% | +5.21% |
| Net income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B |
| EPS (diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
Analyst forecast
ForecastConsensus (29 analysts)
buy
Avg. price target
$104.44+19.02%
- Strong buy 3
- Buy 16
- Hold 10
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Q1 2027)
- Sep 3, 2026
- EPS actual vs est.
- $1.14 vs —
Dividends
Dividend history- Annual dividend
- $2.85
- Dividend yield
- 3.25%
- Last payment
- $0.72
- Ex-dividend date
- Sep 25, 2026
MDT news
All MDT news- Medtronic options flow points to volatility bet with bullish overlay near $90Investing.com
- Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?NasdaqMDT, MMED
- Medtronic Finalizes 4.5939 Exchange Ratio As MiniMed Split-Off Nears CompletionNasdaqMDT, MMED, BRK.A
- Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.PR NewswireMDT, MMED
- Barclays Initiates Coverage of Medtronic at Equal-WeightNasdaqMDT, BCS
- The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.NasdaqMDT, LLY
- Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?NasdaqJNJ, BSX, MDT, SYK
- Medtronic (MDT) Outperforms Broader Market: What You Need to KnowNasdaq
Medtronic peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ITGRInteger Holdings Corporation | 126.65 | +0.05% | $4.31B | vs MDT |
| LIVNLivaNova PLC | 75.91 | -0.03% | $4.17B | vs MDT |
| AXGNAxogen Inc. | 36.18 | +0.39% | $2.12B | vs MDT |
| CNMDCONMED Corporation | 45.11 | +1.99% | $1.35B | vs MDT |
| CBLLCeriBell Inc. | 23.15 | -1.41% | $888.45M | vs MDT |
| INMDInMode Ltd. | 14.08 | +0.50% | $810.22M | vs MDT |
| CVCapsoVision Inc. | 6.62 | +1.22% | $352.25M | vs MDT |
| ELMDElectromed Inc. | 27.80 | -1.42% | $230.38M | vs MDT |
Indexes, lists and sector
Medtronic stock FAQ
What is Medtronic's stock price today?
MDT last traded at $87.75 as of Oct 8, 4:00 PM EDT, up 2.62% on the day. Prices are delayed at least 15 minutes.
Does Medtronic pay a dividend?
Yes. Medtronic pays $2.85 per share annually, a 3.25% yield. The most recent dividend of $0.72 had an ex-dividend date of Sep 25, 2026.
What is MDT's P/E ratio?
MDT trades at a trailing P/E ratio of 21.56 and a forward P/E of 13.68, compared with a median of 22.5 for its closest peers.
Is Medtronic in the S&P 500?
Yes. Medtronic (MDT) is a constituent of the S&P 500 index.
Who is Medtronic's CEO?
Mr. Geoffrey Straub Martha is the chief executive officer of Medtronic plc., which has about 95,000 employees.
Has MDT ever split its stock?
Yes. The most recent MDT stock split was a 2-for-1 split on Sep 27, 1999, one of 7 splits on record.
What is the MDT 52-week high?
The 52-week high for MDT is $106.33 and the 52-week low is $73.31. The stock is currently 17.5% below its high.